Symptoms of Allergic Rhinitis in Women during Early Pregnancy Are Associated with Higher Prevalence of Allergic Rhinitis in Their Offspring  by Shinohara, Miwa et al.
Allergology International Vol 56, No4, 2007 www.jsaweb.jp 411
Symptoms of Allergic Rhinitis in
Women during Early Pregnancy Are
Associated with Higher Prevalence of
Allergic Rhinitis in Their Offspring
Miwa Shinohara1,2, Hiroshi Wakiguchi1, Hirohisa Saito2 and Kenji Matsumoto2
ABSTRACT
Background: Epigenetic control of gene expression profiles is a ubiquitous mechanism during cell differentia-
tion, organogenesis and chronic inflammatory reactions. Recent studies have shown that allergen exposure
during very early pregnancy increases bronchial hypersensitivity in offspring in a murine model of bronchial
asthma. However, no such phenomena were reported in humans. In the present study, the role of epigenetic
control in the onset of allergic diseases was investigated.
Methods: A total of 400 pairs of mothers with physician-diagnosed allergic rhinitis (AR) and their offspring
(age 7―18 months) who participated in a large-scale medical check-up were enrolled in this retrospective cohort
study. Family history of allergic diseases and the presence or absence of AR symptoms during pregnancy were
inquired about using a self-answered questionnaire. A logistic regression model adjusted for age, gender, birth
month and father’s history of allergic diseases was statistically analyzed.
Results: Offspring whose mothers had any AR symptoms during early pregnancy showed a significantly
higher adjusted odds ratio for the onset of AR in offspring than those whose mothers had no symptoms during
pregnancy (adjusted Odds Ratio: 6.26, p = 0.036). However, the symptoms of AR during late pregnancy
showed no effects on the odds ratio. In contrast, the presence or absence of AR symptoms during early or late
pregnancy showed no association with the prevalence of food allergy, atopic dermatitis or asthma in offspring.
Conclusions: Our results suggest the presence of possible epigenetic mechanisms regulating the onset of
AR in humans presumably through increased organ-specific hypersensitivity.
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INTRODUCTION
During the ontogenesis of multicellular organisms, a
single cell proliferates and differentiates into many
different cell types each with a unique function and
gene expression pattern. This fact clearly indicates
that additional information beyond that generated by
the genetic sequence must be present in the genera-
tion of the diversity of genomic expression, because
all somatic cells in a single organism possess an iden-
tical set of chromosomes with identical sequences.
Epigenetics is the term used to describe such mei-
otically and mitotically heritable changes in gene ex-
pression that are not coded in the DNA sequence it-
self.1 The molecular mechanisms by which gene ex-
pression is epigenetically regulated are explained by
DNA methylation and chromatin modifications, in-
cluding histone acetylation, methylation, ubiquitina-
tion, sumoylation and phosphorylation.2 Epigenetic
regulation is not only critical for generating diversity
of cell types during mammalian development, but is
also important for maintaining the stability and integ-
rity of the expression profiles of different cell types.1
In this respect, disruption of epigenetic control leads
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to several major pathologies, including cancer and
syndromes involving chromosomal instabilities.3 It is
also known that several mechanical stresses, such as
radiation, malnutrition, and exposure to certain drugs
and smoking can induce epigenetic changes in hu-
mans.4 Thus, epigenetic changes are potential targets
for therapeutic interventions.2
In chronic inflammatory diseases such as bronchial
asthma and allergic rhinitis (AR),5 chronic exposure
to certain cytokines or chronic inflammation itself can
also induce epigenetic changes in cells in target tis-
sues.6,7 In most cases, such changes support the per-
petuation of chronic inflammatory reactions and
might lead to resistance against therapeutic agents
such as corticosteroids.8
On the other hand, intrauterine events can also af-
fect offspring development through epigenetic
mechanisms. For instance, maternal nutrition during
pregnancy is reported to be associated with the onset
of metabolic syndromes in adult offspring.9 Recently,
Hamada et al. reported that maternal exposure to al-
lergens during very early pregnancy in a mouse
model of bronchial asthma significantly increased
bronchial hypersensitivity and allergic inflammation
in offspring.10 However to date, no report has pre-
sented clear evidence that allergic symptoms of
mothers during pregnancy affect the onset of allergic
diseases in human offspring. In the present study, we
attempted to clarify whether or not such an epige-
netic control mechanism is present and involved in
the onset of AR in the offspring.
METHODS
SUBJECTS
A total of 400 pairs of mothers with physician-
diagnosed AR and their offspring (187 boys and 211
girls, age 1.7―18.7 months) who participated in a
large-scale medical check-up was enrolled in this ret-
rospective cohort study. Mothers were enrolled only
if the guardian’s answer to the question, “Has the
mother of the child ever received a diagnosis of aller-
gic rhinitis by a doctor?” was “Yes”. Along with the
age and the gender of the offspring, paternal history
of allergic diseases and the presence or absence of
the symptoms of AR in parents during pregnancy
were inquired about using a self-answered question-
naire. The presence of AR symptoms during preg-
nancy was based on the guardian’s response to the
question, “Has the mother of the child showed any
symptoms of allergic rhinitis during the pregnancy?”
In this study, the first and the second half of the ges-
tation period was considered to be early and late
pregnancy, respectively. The primary outcome meas-
ure was the presence of physician-diagnosed allergic
diseases in the offspring. The diagnosis of AR in the
offspring was made only if the guardian’s answer to
the question, “Has your child ever received a diagno-
sis of allergic rhinitis by a doctor?” was “Yes”. The
prevalence of other allergic disease was also deter-
mined similarly. This study was approved by the Eth-
ics Review Board of Kochi Medical School.
STATISTICS
A logistic regression model adjusted for age, gender,
birth month of the offspring and paternal history of al-
lergic diseases was analyzed using STATA software
(StataCorp LP, College Station, TX, USA) and consid-
ered to be significant if p < 0.05.
RESULTS
DESCRIPTIVE CHARACTERISTICS OF THE OFF-
SPRING
Initially, the offspring enrolled in this study were di-
vided into three groups in the context of the presence
or absence of symptoms of AR in their mothers dur-
ing pregnancy. The descriptive characteristics of the
three groups were compared (Table 1). The malefe-
male proportion did not differ among these three
groups (p = 0.681). However, age and the prevalence
of a paternal history of allergic diseases were not the
same in these three groups (p = 0.010 and 0.005, re-
spectively). In addition, the month of birth differed
significantly among these three groups (χ2 = 18.95,
p = 0.0001). In particular, the month of birth of off-
spring whose mothers had symptoms of AR during
early pregnancy was not unimodal throughout the
year, the frequency being higher in the September to
November period.
ASSOCIATION BETWEEN THE SYMPTOMS OF
AR IN MOTHERS DURING PREGNANCY AND
THE PREVALENCE OF AR IN THEIR OFFSPRING
In order to determine the association between symp-
toms of AR in mothers during pregnancy and the
prevalence of AR in their offspring, detailed informa-
tion was obtained from all subjects. According to the
differences in background shown in Table 1, a logis-
tic regression model adjusted for age, gender, birth
month of the offspring and paternal history of allergic
diseases was analyzed (Table 2). The presence of
symptoms of AR in mothers during early pregnancy
was associated with a significantly higher prevalence
of AR in their offspring (adjusted odds ratio: 6.332,
95% CI: 1.134―35.360, p = 0.035). In contrast, no such
association was found between symptoms of AR in
mothers during late pregnancy and the prevalence of
AR in their offspring (adjusted odds ratio: 0.476, 95%
CI: 0.115―1.976, p = 0.307). Some mothers had AR
symptoms during both early and late pregnancy. In
the offspring of these mothers, the prevalence of AR
was not high enough to reach statistical significance
(adjusted OR: 1.472, 95% CI: 0.398―5.448). This result
is reasonable because only symptoms during early
pregnancy, and not late pregnancy, were significantly
correlated with a higher prevalence of AR in the off-
spring.
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Table 1 Descriptive characteristics of ofspring enroled in this study
p value
Symptoms of Alergic Rhinitis during Pregnancy in Mothers
Confounding
Factors LateEarlyNoneTotal
Data †(n ＝ 173)Data †(n ＝ 219)Data †(n ＝ 150)Data †(n ＝ 400)
0.010 ＊ 9.7 (2.6―18.0)  9.0 (1.7―18.4) 10.7 (2.7―18.7)  9.9 (1.7―18.7)Age (mo)‡
Gender §
0.681 
76 (44.4) 105 (48.4) 67 (44.7) 187 (47.0) Male
95 (55.6) 112 (51.6) 83 (55.3) 211 (53.0) Female
Month of Birth §
 0.0001 ＊
13 ( 7.6%) 16 ( 7.3%)19 (12.8%) 36 ( 9.1%)January
 8 ( 4.7%)  7 ( 3.2%)14 ( 9.4%) 24 ( 6.0%)February
15 ( 8.7%) 12 ( 5.5%) 7 ( 4.7%) 24 ( 6.0%)March
15 ( 8.7%) 13 ( 6.0%) 8 ( 5.4%) 24 ( 6.0%)April
20 (11.6%) 11 ( 5.0%)11 ( 7.4%) 32 ( 8.0%)May
12 ( 7.0%) 11 ( 5.0%)14 ( 9.4%) 29 ( 7.3%)June
13 ( 7.6%) 18 ( 8.3%)11 ( 7.4%) 30 ( 7.5%)July
14 ( 8.1%) 18 ( 8.3%) 8 ( 5.4%) 29 ( 7.3%)August
14 ( 8.1%) 27 (12.4%)10 ( 6.7%) 37 ( 9.3%)September
14 ( 8.1%) 29 (13.3%)15 (10.1%) 44 (11.1%)October
16 ( 9.3%) 32 (14.7%)15 (10.1%) 47 (11.8%)November
18 (10.5%) 24 (11.0%)17 (11.4%) 42 (10.6%)December
Paternal History of Alergic Diseases §
0.005 ＊
94 (54.3) 112 (51.1) 56 (37.3) 187 (46.8) No
79 (45.7) 107 (48.9) 94 (62.7) 213 (53.3) Yes
†Mean value or number of ofspring, and percent, range or SD.
‡Kruskal-Walis test.
§ χ2 test. ＊p ＜ 0.05.
Table 2 Association of the prevalence of alergic rhinitis in ofspring with alergic rhinitis symptoms in mothers during pregnancy
p value(95% CI)aOR †(95% CI)OR(%)
Alergic
Rhinitis
Yes/No
Alergic Rhinitis
(n ＝ 10)
Total (n ＝ 400)
0.051 (1.000―1.010)1.005(0.999―1.009)1.004Age
Gender
1.0001.000(3.7)7/180Male
0.226 (0.103―1.672)0.416(0.095―1.455)0.371(1.4)3/208Female
0.932 (0.832―1.184)0.992(0.826―1.174)0.985Month of Birth
Paternal History of Alergic Diseases
1.0001.000(2.1)4/183No
0.175 (0.611―15.010)3.027(0.368―4.772)1.326(2.8)6/207Yes
Symptoms of Alergic Rhinitis in Mothers
During Pregnancy
1.0001.000(1.3)2/148None
0.157 (0.638―16.101)3.204(0.513―11.675)2.446(3.2)8/242Anytime
Early Pregnancy
1.0001.000(1.1)2/179No
 0.035＊(1.134―35.360)6.332(0.711―16.185)3.393(3.7)8/211Yes
Late Pregnancy
1.0001.000(2.6)6/221No
0.307 (0.115―1.976)0.476(0.242―3.138)0.872(2.3)4/169Yes
†Adjusted odds ratio and 95% confidence intervals for alergic rhinitis in ofspring were calculated by logistic regression analysis after 
adjustment for age, gender, paternal history of alergic diseases and month of birth.
＊p ＜ 0.05.
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Table 3 Associations of the prevalence of other alergic diseases in ofspring with the symptoms of alergic rhinitis in mothers 
during pregnancy
p value(95% CI)aOR †(95% CI)OR(%)
Alergic
Diseases
Yes/No
Alergic Disease of
Ofspring
Total (n ＝ 400)
Bronchial Asthma
Symptoms of Alergic Rhinitis in Mothers
During Pregnancy
1.0001.000(2.0) 3/147None
0.979(0.190―5.496)1.023(0.119―2.987)0.595(1.2) 3/247Anytime
Early Pregnancy
1.0001.000(1.7) 3/178No
0.422(0.283―20.317)2.399(0.164―4.133)0.824(1.4) 3/216Yes
Late Pregnancy
1.0001.000(1.8) 4/223No
0.459(0.042―4.189)0.419(0.118―3.602)0.652(1.2) 2/171Yes
Food Alergy
Symptoms of Alergic Rhinitis in Mothers
During Pregnancy
1.0001.000(4.7) 7/143None
0.211(0.720―4.442)1.788(0.519―3.275)1.304(6.0)15/235Anytime
Early Pregnancy
1.0001.000(5.0) 9/172No
0.379(0.555―4.714)1.617(0.503―2.889)1.206(5.9)13/206Yes
Late Pregnancy
1.0001.000(4.8)11/216No
0.854(0.383―3.180)1.104(0.564―3.151)1.333(6.4)11/162Yes
Atopic Dermatitis
Symptoms of Alergic Rhinitis in Mothers
During Pregnancy
1.0001.000(4.7) 7/143None
0.211(0.225―1.390)0.559(0.733―4.307)1.776(8.0)20/230Anytime
Early Pregnancy
1.0001.000(4.4) 8/173No
 0.144(0.776―5.681)2.099(0.877―4.810)2.054(8.7)19/200Yes
Late Pregnancy
1.0001.000(6.2)14/213No
0.858(0.374―2.270)0.921(0.565―2.702)1.236(7.5)13/160Yes
†Adjusted odds ratio and 95% confidence intervals for other alergic diseases in ofspring were calculated by logistic regression analy
sis after adjustment for age, gender, paternal history of alergic diseases and month of birth.
To confirm the validity of the logistic regression
model, we determined the post-estimation goodness-
of-fit parameter for this logistic regression model us-
ing the Hosmer-Lemeshow goodness-of-fit test and
found the model to be valid (p = 0.5027). Thus, we are
convinced of the statistical significance of this study,
even though the number of offspring with AR was
relatively small.
In addition, the effect of maternal smoking and the
exposure of the mothers to passive smoking during
pregnancy was included in the present logistic re-
gression model. Maternal smoking and the exposure
of the mothers to passive smoking during pregnancy
is known to be a strong confounding factor for the on-
set of AR11; however, even after these factors were
considered, the adjusted odds ratio was virtually un-
changed (data not shown).
ASSOCIATION BETWEEN THE SYMPTOMS OF
AR IN MOTHERS DURING PREGNANCY AND
THE PREVALENCE OF OTHER ALLERGIC DIS-
EASES IN THEIR OFFSPRING
Just as in the aforementioned analysis, the associa-
tion between symptoms of AR in mothers during
pregnancy and the prevalence of other allergic dis-
eases in their offspring was determined (Table 3). No
significant association was observed between symp-
toms of AR in mothers during either early or late
Epigenetic Control of Allergic Rhinitis
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Table 4 Association of the prevalence of alergic rhinitis in ofspring with the symptoms of alergic rhinitis in fathers during 
pregnancy
p value(95% CI)aOR†(95% CI)OR(%)
Alergic
Rhinitis
Yes/No
Alergic Rhinitis
(n ＝ 10)
Total (n ＝ 400)
0.114(0.999―1.001)1.004(0.999―1.009)1.004Age
Gender
1.0001.000(3.7)7/180Male
0.232(0.108―1.715)0.429(0.095―1.455)0.371(1.4)3/208Female
0.879(0.832―1.171)0.987(0.826―1.174)0.985Birth Months
Symptoms of Alergic Rhinitis in Fathers
During Pregnancy
1.0001.000(2.7)8/286None
0.513(0.100―3.151) 0.563(0.144―3.290)0.688(1.9)2/104Anytime
Early Pregnancy
1.0001.000(2.6)8/300No
 0.300(0.426―15.989)2.609(0.174―3.995)0.833(2.2)2/90 Yes
Late Pregnancy
1.0001.000(3.1)10/309 No
/////(0.0)0/81 Yes
†Adjusted odds ratio and 95% confidence intervals for alergic rhinitis in ofspring were calculated by logistic regression analysis after 
adjustment for age, gender and month of birth.
pregnancy and the prevalence of either physician-
diagnosed bronchial asthma, food allergy or atopic
dermatitis in their offspring.
ASSOCIATION BETWEEN THE SYMPTOMS OF
AR IN FATHERS DURING PREGNANCY AND
THE PREVALENCE OF AR IN THEIR OFFSPRING
Just as in the aforementioned two analyses, the asso-
ciation between symptoms of AR in fathers during
pregnancy and the prevalence of AR in their offspring
was determined (Table 4). No significant association
was observed between symptoms of AR in fathers
during either early or late pregnancy and the preva-
lence of AR in their offspring. In addition, there was
no significant association between symptoms of AR in
fathers during either early or late pregnancy and the
prevalence of physician-diagnosed bronchial asthma,
food allergy or atopic dermatitis in their offspring
(data not shown).
DISCUSSION
Epigenetic control of gene expression profiles is a
ubiquitous mechanism during cell differentiation, or-
ganogenesis and chronic inflammatory reactions.1 A
recent study showed that allergen exposure during
very early pregnancy increased bronchial hypersensi-
tivity and allergic inflammation in offspring in a
murine model of bronchial asthma,10 but no such
phenomena have been reported in humans. In the
present study, mothers with physician-diagnosed AR,
from whom detailed information about their preg-
nancy and offspring could be obtained, were enrolled.
Before starting the statistical analysis, we carefully
considered the descriptive characteristics of the off-
spring who were divided into three groups in the con-
text of the presence or absence of symptoms of AR in
their mothers during pregnancy (Table 1). These
characteristics are known to be common confounding
factors for the onset of allergic diseases.12,13 The gen-
der ratio of offspring did not differ among these three
groups. However, age and the prevalence of the pa-
ternal history of allergic diseases were not the same
in these three groups. In addition, the month of birth
also differed among them, presumably because the
season for the major allergen of rhinitis, Japanese Ce-
dar pollen, is exclusively March to May.14,15 In con-
trast, the frequency of offspring whose mothers had
symptoms during late pregnancy was slightly higher
in March to May, as expected. In order to eliminate
the effect of the month of birth and so on, these fac-
tors were considered and adjusted for in our logistic
regression model. In other words, our statistical
analysis allowed us to determine the effect of symp-
toms of the mothers free of the influence of the differ-
ence in birth month profile.
After consideration of these confounding factors,
we found that the presence of symptoms of AR in
mothers during early but not late pregnancy was sig-
nificantly associated with a higher prevalence of AR
in their offspring (Table 2). The fact that the positive
association was found only in the offspring with
symptoms during early pregnancy, i.e. not in those
with symptoms during late pregnancy, strongly sug-
gests that this association is not due simply to the se-
verity of the mothers’ rhinitis or genetic predisposi-
tion but rather to some mechanisms operating spe-
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cifically during early pregnancy, which is the time
when organogenesis is being undertaken. It was pre-
viously reported that allergen exposure just before
mating was critical to producing increased bronchial
hyperreactivity of offspring in a mouse model of
asthma, while exposure during late pregnancy
showed no effect.10 Our findings are highly compat-
ible with this previous report and emphasize that the
maternal allergic reactions during very early preg-
nancy are critical.
Note that symptoms of AR in mothers correlated
only with a higher prevalence of AR, not with those of
other allergic diseases such as bronchial asthma,
food allergy or atopic dermatitis in their offspring
(Table 3). It is now well-understood that both atopy
(hyper secretion of antigen-specific IgE) and organ-
specific hypersensitivity regulate the onset and phe-
notype of allergic diseases.16 Together with this ob-
servation, our results suggest that the symptoms of
AR in mothers during early pregnancy do not influ-
ence IgE production in their offspring but rather their
organ-specific (nasal) hypersensitivity. In fact, T cells
from fetuses acquire the ability to mount a prolifera-
tive response to a common allergic trigger (β-
lactoglobulin, house dust mite, etc) only after 22
weeks of pregnancy.17 Thus, T cells may not be the
target of this effect or T cells may not even exist dur-
ing this period in the fetus.
In order to confirm that the positive association we
found is mother-specific, we also tested the effect of
paternal symptoms. The fathers’ symptoms of AR
during either early or late pregnancy showed no cor-
relation with the prevalence of AR in their offspring
(Table 4). Thus, this effect does not reflect simply the
transfer of genetic predisposition from the parents or
the dose of allergen exposure during that period, but
rather is maternal symptom-specific.
Taken together, our findings imply the presence of
possible mechanisms that can transfer susceptibility
to AR or organ-specific hypersensitivity from preg-
nant women to their offspring when AR symptoms oc-
cur during early, but not late, pregnancy. The data
suggest that this phenomenon cannot simply be ex-
plained by genetic transfer of the allergic predisposi-
tion from the parent to the offspring. Some intrauter-
ine events have actually been reported to be associ-
ated with the onset of allergic diseases in offspring.18
However, the time of exposure and the target of the
effect clearly differ from the observations made in
this study. Our results taken together thus support
the presence of epigenetic control of gene expression
profiles in susceptibility to AR in offspring rather than
a simple transfer of genetic predispositions.
Recent studies of the molecular basis of epigene-
tics have shown that DNA methylation and chromatin
modifications, including histone acetylation, methyla-
tion, ubiquitination, sumoylation and phosphorylation
are the main mechanisms underlying such phenom-
ena.2 However, which gene loci are selectively modu-
lated or how such loci are selected is essentially un-
known. Hamada et al. have suggested that premating
treatment with neutralizing anti-IL-4 antibody abro-
gated the maternal effect.10 However, it is as yet un-
known whether IL-4 critically regulates allergic symp-
toms directly and thus epigenetic transfer was inhib-
ited or epigenetic modulation of the IL-4 gene locus is
critical. On the other hand, it was reported that ad-
ministration of IFN-γ to the pregnant female mouse
during middle pregnancy (gestation day 6.5) dimin-
ished the Th2 immune responses in their offspring.19
In that case, IFN-γ administration is likely to affect im-
mune cell generation in the offspring directly or indi-
rectly, and thus the time of exposure and the target of
modification appear to be critically different from
those in our study. In the present study, genes or loci
responsible for the transfer of the higher prevalence
of AR or nasal hypersensitivity are very likely to be in-
volved. However, identification of the genes or loci re-
quires further investigations.
It has been widely reported that the prevalence of
several allergic diseases differs depending on the
birth month of the subjects in several countries.20-22
Such differences in allergic disease prevalence or
sensitization to seasonal allergens were explained by
the immature immune responses of infants with high
perinatal exposure to allergens. However, recent in-
tervention studies have suggested that the dose of al-
lergen exposure prenatally or during early infancy
has only marginal effects on the allergy sensitization
of the offspring.23,24 Together with our results, these
findings suggest that maternal allergic symptoms
during early pregnancy, rather than early-life expo-
sure to the allergen, might be a more important con-
founding factor. In addition, in Japan the prevalence
of AR is reportedly higher in subjects born in autumn
to winter.14,25 Our results confirmed this tendency
(Table 1) and in addition, imply the involvement of an
epigenetic effect of maternal exposure to the allergen
in this tendency.
In the present study, only young children, less than
two years of age, were enrolled. It is unknown
whether this influence might be enhanced or dimin-
ished by the interaction with environmental factors
later in life. Though the number is not large, we
found for the first time in humans a statistically sig-
nificant correlation between the symptoms of moth-
ers and a higher prevalence of AR in their offspring.
This study has some limitations. First, the diagno-
sis of AR was questionnaire-based, and no laboratory
data, including the total IgE or allergen-specific IgE
titers, were measured. Second, the pregnancy period
was divided into only two groups because the num-
ber of offspring given a diagnosis of AR was relatively
small. Further detailed analysis will be necessary to
specify the critical period during pregnancy. Finally,
as this is a retrospective cohort study, a controlled in-
Epigenetic Control of Allergic Rhinitis
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tervention study should also be performed in the near
future.
Our results suggest not only the presence of epige-
netic control in the onset of allergic diseases in hu-
mans but also suggest the clinical importance of ag-
gressive control of AR symptoms in women during
early pregnancy; the best strategy being allergen
avoidance.26,27
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